Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
71,194.63
(
-2.58%
)
News Focus
News Focus
Post# of 129997
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

researcher59

Send PM Follow Ignore
Followers 330
Posts 33608
Boards Moderated 22
Alias Born 12/30/2004

researcher59

Member Level

Re: SSKILLZ1 post# 123675

Monday, 11/17/2025 10:26:47 AM

Monday, November 17, 2025 10:26:47 AM

Post# of 129997
JAZZ +27 to 168 after reporting positive phase 3 trial data -

briefing -

Jazz Pharma reports HERIZON-GEA-01 Phase 3 results supporting Ziihera (141.07 ) : Ziihera plus chemotherapy showed a clinically meaningful and statistically significant improvement in PFS versus trastuzumab and chemotherapy, and a clinically meaningful effect with a strong trend toward statistical significance for OS at the first OS interim analysis
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today